Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Conditions
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Gastric Cancer
- Head and Neck Cancer
- Liver Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: capecitabine
- DRUG: carboplatin
- DRUG: epirubicin hydrochloride
Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators